Active PriorityDeveloping
Moderna Shares Surge on Undisclosed Cancer Vaccine Data; Minnesota Official Charged in $1M Medicaid Fraud
worth trackingUpdated 3h ago
Key takeaway: Moderna's stock experienced a significant increase following preliminary positive Phase 3 trial results for its melanoma vaccine, while a Minnesota state-honored individual was charged with over $1 million in Medicaid fraud.
